These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16865412)

  • 21. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
    Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
    Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic heritability at birth: implications for chronic disease research.
    Ryckman KK; Smith CJ; Jelliffe-Pawlowski LL; Momany AM; Berberich SL; Murray JC
    Hum Genet; 2014 Aug; 133(8):1049-57. PubMed ID: 24850141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disorders of the carnitine cycle and detection by newborn screening.
    Wilcken B
    Ann Acad Med Singap; 2008 Dec; 37(12 Suppl):71-3. PubMed ID: 19904456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newborn screening for citrin deficiency and carnitine uptake defect using second-tier molecular tests.
    Wang LY; Chen NI; Chen PW; Chiang SC; Hwu WL; Lee NC; Chien YH
    BMC Med Genet; 2013 Feb; 14():24. PubMed ID: 23394329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Familial carnitine transporter defect: A treatable cause of cardiomyopathy in children.
    Pierpont ME; Breningstall GN; Stanley CA; Singh A
    Am Heart J; 2000 Feb; 139(2 Pt 3):S96-S106. PubMed ID: 10650322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiomyopathy and carnitine deficiency.
    Amat di San Filippo C; Taylor MR; Mestroni L; Botto LD; Longo N
    Mol Genet Metab; 2008 Jun; 94(2):162-6. PubMed ID: 18337137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of L-carnitine in cellular metabolism: beyond Acyl-CoA transport.
    Chapela SP; Kriguer N; Fernández EH; Stella CA
    Mini Rev Med Chem; 2009 Nov; 9(13):1518-26. PubMed ID: 20205633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocardial fibroelastosis and primary carnitine deficiency due to a defect in the plasma membrane carnitine transporter.
    Bennett MJ; Hale DE; Pollitt RJ; Stanley CA; Variend S
    Clin Cardiol; 1996 Mar; 19(3):243-6. PubMed ID: 8674264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Na+/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment.
    Ohnishi S; Okamura N; Sakamoto S; Hasegawa H; Norikura R; Kanaoka E; Takahashi K; Horie K; Sakamoto K; Baba T
    Drug Metab Pharmacokinet; 2008; 23(4):293-303. PubMed ID: 18762717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acylcarnitine profiles of preterm infants over the first four weeks of life.
    Meyburg J; Schulze A; Kohlmueller D; Pöschl J; Linderkamp O; Hoffmann GF; Mayatepek E
    Pediatr Res; 2002 Nov; 52(5):720-3. PubMed ID: 12409519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carnitine uptake defect: frameshift mutations in the human plasmalemmal carnitine transporter gene.
    Lamhonwah AM; Tein I
    Biochem Biophys Res Commun; 1998 Nov; 252(2):396-401. PubMed ID: 9826541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Blood spot carnitine and acylcarnitine in newborn to adolescence: measured by tandem mass spectrometry].
    Gong ZH; Tian GL; Wang YM
    Zhonghua Er Ke Za Zhi; 2010 Dec; 48(12):922-7. PubMed ID: 21215187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exome sequencing identifies primary carnitine deficiency in a family with cardiomyopathy and sudden death.
    Lahrouchi N; Lodder EM; Mansouri M; Tadros R; Zniber L; Adadi N; Clur SB; van Spaendonck-Zwarts KY; Postma AV; Sefiani A; Ratbi I; Bezzina CR
    Eur J Hum Genet; 2017 Jun; 25(6):783-787. PubMed ID: 28295041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy.
    Tein I
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2.
    Spiekerkoetter U; Huener G; Baykal T; Demirkol M; Duran M; Wanders R; Nezu J; Mayatepek E
    J Inherit Metab Dis; 2003; 26(6):613-5. PubMed ID: 14605509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype.
    Morris AA; Olpin SE; Brivet M; Turnbull DM; Jones RA; Leonard JV
    J Pediatr; 1998 Mar; 132(3 Pt 1):514-6. PubMed ID: 9544911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postnatal changes in neonatal acylcarnitine profile.
    Meyburg J; Schulze A; Kohlmueller D; Linderkamp O; Mayatepek E
    Pediatr Res; 2001 Jan; 49(1):125-9. PubMed ID: 11134502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First prenatal diagnosis of the carnitine transporter defect.
    Christodoulou J; Teo SH; Hammond J; Sim KG; Hsu BY; Stanley CA; Watson B; Lau KC; Wilcken B
    Am J Med Genet; 1996 Dec; 66(1):21-4. PubMed ID: 8957505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.